Sign in

CIK 0000882796

  • Large accelerated filer

BIOCRYST PHARMACEUTICALS INC

Sign in to watch
Ticker
BCRX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
621413174
Phone
+1 919-859-1302
Business address
4505 EMPEROR BOULEVARD, SUITE 200, DURHAM, NC, 27703
  1. 4 Planned sale Chief Legal Officer sold 62,500 shares at $9.54 ($596,250)
  2. 4 Grant or award Chief R&D Officer acquired 205,150 shares (grant or award)
  3. 3 Insider Initial Statement of Ownership
  4. 4 Open-market sale Director sold 49,933 shares at $10.11 ($504,823)
  5. 4 Planned sale Chief Legal Officer sold 150,000 shares at $9.15 ($1,372,500)
  6. 4 Grant or award Director acquired 528 shares (grant or award)
  7. 4 Returned to the company Director returned 305,995 shares (to the company)
  8. 4 Grant or award Director acquired 848 shares (grant or award)
  9. 4 Grant or award Director acquired 1,285 shares (grant or award)
  10. 4 Grant or award Director acquired 642 shares (grant or award)
  11. 4 Grant or award Director acquired 14,854 shares (grant or award)
  12. 3 Insider Initial Statement of Ownership
  13. 3 Insider Initial Statement of Ownership
  14. 4 Shares withheld for taxes Chief Executive Officer gave up 61,793 shares (to pay taxes)
  15. 4 Planned sale Chief Legal Officer sold 21,773 shares at $7.65 ($166,563)
  16. 4 Option exercise President and CCO acquired 74,233 shares (option exercise)
  17. 4 Gift Chief Executive Officer gave 20,000 shares (gift)
  18. 4 Grant or award President and CCO acquired 471,000 shares (grant or award)
  19. 4 Grant or award Chief Legal Officer acquired 121,700 shares (grant or award)
  20. 4 Grant or award Chief Financial Officer acquired 121,700 shares (grant or award)

Page 2 of 49 · 965 filings